17-61456524-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001321120.2(TBX4):c.34G>A(p.Glu12Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000914 in 1,565,320 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001321120.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX4 | ENST00000644296.1 | c.34G>A | p.Glu12Lys | missense_variant | Exon 2 of 9 | NM_001321120.2 | ENSP00000495986.1 | |||
TBX4 | ENST00000240335.1 | c.34G>A | p.Glu12Lys | missense_variant | Exon 1 of 8 | 1 | ENSP00000240335.1 | |||
TBX4 | ENST00000642491.1 | c.34G>A | p.Glu12Lys | missense_variant | Exon 1 of 8 | ENSP00000495714.1 | ||||
TBX4 | ENST00000589003.5 | c.-125-100G>A | intron_variant | Intron 1 of 5 | 3 | ENSP00000467588.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152158Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000100 AC: 17AN: 169496Hom.: 0 AF XY: 0.0000987 AC XY: 9AN XY: 91202
GnomAD4 exome AF: 0.0000899 AC: 127AN: 1413162Hom.: 0 Cov.: 32 AF XY: 0.0000888 AC XY: 62AN XY: 698548
GnomAD4 genome AF: 0.000105 AC: 16AN: 152158Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74312
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 12 of the TBX4 protein (p.Glu12Lys). This variant is present in population databases (rs756802394, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with TBX4-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TBX4 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at